AstraZeneca sees higher 2022 sales even as COVID boost wanes

AstraZeneca raised its annual
dividend for the first time in a decade on Thursday and forecast
higher sales for 2022 as new drugs against cancer, kidney
disease and rare conditions make up for a... | February 10, 2022

Related Keywords

United States ,Bengaluru ,Karnataka ,India ,London ,City Of ,United Kingdom ,America ,Josephine Mason ,Astrazeneca Chadox ,Mark Potter ,Ludwig Burger ,Pushkala Aripaka ,Jason Neely ,Pascal Soriot ,Pfizer ,Astrazeneca ,Oxford University ,Reuters ,Executive Pascal Soriot ,Latin America ,Southeast Asia ,London Editing ,Astrazeneca Plc Stock Exchange ,News ,Information ,Press Release ,Aised ,Its ,Or ,The ,First ,Dime ,N ,Ecade ,Hursday ,End ,Sales ,022 ,Us ,Few ,Drugs ,Against ,Mare ,Conditions ,Lake ,P ,For Azn Gb0009895292 ,